-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Initiates Coverage On Bright Minds Biosciences with Outperform Rating, Announces Price Target of $150

Benzinga·10/15/2026 11:55:59
语音播报
Wolfe Research initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a Outperform rating and announces Price Target of $150.